mlif elisa kit Search Results


mlif elisa kit  (R&D Systems)
95
R&D Systems mlif elisa kit
(A) lif expression in the scRNA-seq from mouse livers with acetaminophen (APAP)-induced injury at the indicated time points. (B) lif expression in the scRNA-seq across cell types in the livers of mouse with APAP injury at the indicated time points. (C) lif expression in spatial transcriptomics of liver samples from healthy (HEA2) and APAP injury (APAP1_S2) humans. (D&E) Serum <t>mLIF</t> levels at 24, 48, and 72 h after partial hepatectomy (PHx) in mice treated with IgG (D) or anti-LIF neutralizing antibody (E). (F) Resected liver-to-body weight ratio in mice treated with anti-LIF antibody or control IgG. (G) Liver-to-body weight ratio at 24, 48, 72 h and 1-week post-PHx in mice treated with anti-LIF antibody or control IgG. (H) Immunofluorescence staining of liver sections at 48 h post-PHx from mice treated with anti-LIF antibody or control IgG. DAPI (blue), PCNA (red), CK19 (purple). Scale bars: 100 μm. (I) Quantification of PCNA-positive hepatocytes ratio at 48 h post-PHx in mice treated with anti-LIF antibody or control IgG.
Mlif Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mlif+elisa+kit/Mouse+LIF+Quantikine+ELISA+Kit/bio_rxiv__64898__2026__02__24__707802-245-12-15
Average 95 stars, based on 1 article reviews
mlif elisa kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
human gremlin-2(grem2) elisa kit  (Cusabio)
N/A
Human Gremlin-2(GREM2) ELISA kit
   Buy from Supplier
human gremlin 1 elisa kit (chemiluminescence)  (Novus Biologicals)
N/A
Human Gremlin 1 ELISA Kit (Chemiluminescence)
   Buy from Supplier
human gremlin 2 (dan domain family member 3) elisa kit  (Innovative Research Inc)
N/A
This Human Gremlin 2 (DAN Domain Family Member 3) ELISA Kit from Innovative Research is intended for quantitative detection of human GREM2 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). Strip well
   Buy from Supplier
human grem1 (gremlin 1) elisa kit  (Elabscience Biotechnology)
N/A
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GREM1. Standards or samples are added to the micro ELISA plate
   Buy from Supplier
human gremlin 1  (Shanghai Korain Biotech Co Ltd)
N/A
Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop. Down-regulates the BMP4 signaling in
   Buy from Supplier
human gremlin 1 elisa kit  (Innovative Research Inc)
N/A
Human Gremlin 1 ELISA Kit from Innovative Research is intended for the quantitative determination of Human Gremlin 1 in biofluid samples, such as serum, plasma, tissue homogenates, urine and other biological fluids. This is a
   Buy from Supplier
rat gremlin elisa kit  (Cusabio)
N/A
Rat Gremlin ELISA Kit
   Buy from Supplier
mouse gremlin 1 (grem1) elisa kit  (Bioss)
N/A
   Buy from Supplier
mouse gremlin-1 elisa  (RayBiotech inc)
N/A
RayBio® Mouse Gremlin-1 ELISA Kit for cell culture supernatants, EDTA treated plasma, and serum samples. Heparin and citrate are not recommended.
   Buy from Supplier
mouse gremlin 1 elisa kit (chemiluminescence)  (Novus Biologicals)
N/A
Mouse Gremlin 1 ELISA Kit (Chemiluminescence)
   Buy from Supplier
human gremlin-1(grem1) elisa kit  (Cusabio)
N/A
Human Gremlin-1(GREM1) ELISA kit
   Buy from Supplier

Image Search Results


(A) lif expression in the scRNA-seq from mouse livers with acetaminophen (APAP)-induced injury at the indicated time points. (B) lif expression in the scRNA-seq across cell types in the livers of mouse with APAP injury at the indicated time points. (C) lif expression in spatial transcriptomics of liver samples from healthy (HEA2) and APAP injury (APAP1_S2) humans. (D&E) Serum mLIF levels at 24, 48, and 72 h after partial hepatectomy (PHx) in mice treated with IgG (D) or anti-LIF neutralizing antibody (E). (F) Resected liver-to-body weight ratio in mice treated with anti-LIF antibody or control IgG. (G) Liver-to-body weight ratio at 24, 48, 72 h and 1-week post-PHx in mice treated with anti-LIF antibody or control IgG. (H) Immunofluorescence staining of liver sections at 48 h post-PHx from mice treated with anti-LIF antibody or control IgG. DAPI (blue), PCNA (red), CK19 (purple). Scale bars: 100 μm. (I) Quantification of PCNA-positive hepatocytes ratio at 48 h post-PHx in mice treated with anti-LIF antibody or control IgG.

Journal: bioRxiv

Article Title: The LIF-LIFR Axis Promotes Liver Regeneration via Modulation of Angiogenesis and HGF Release from LSECs

doi: 10.64898/2026.02.24.707802

Figure Lengend Snippet: (A) lif expression in the scRNA-seq from mouse livers with acetaminophen (APAP)-induced injury at the indicated time points. (B) lif expression in the scRNA-seq across cell types in the livers of mouse with APAP injury at the indicated time points. (C) lif expression in spatial transcriptomics of liver samples from healthy (HEA2) and APAP injury (APAP1_S2) humans. (D&E) Serum mLIF levels at 24, 48, and 72 h after partial hepatectomy (PHx) in mice treated with IgG (D) or anti-LIF neutralizing antibody (E). (F) Resected liver-to-body weight ratio in mice treated with anti-LIF antibody or control IgG. (G) Liver-to-body weight ratio at 24, 48, 72 h and 1-week post-PHx in mice treated with anti-LIF antibody or control IgG. (H) Immunofluorescence staining of liver sections at 48 h post-PHx from mice treated with anti-LIF antibody or control IgG. DAPI (blue), PCNA (red), CK19 (purple). Scale bars: 100 μm. (I) Quantification of PCNA-positive hepatocytes ratio at 48 h post-PHx in mice treated with anti-LIF antibody or control IgG.

Article Snippet: The following steps were carried out according to the manufacturer’s protocols from mLIF ELISA kit (R&D system, MLF00).

Techniques: Expressing, Spatial Transcriptomics, Control, Immunofluorescence, Staining

(A-C) Body weight (A), liver weight (B) and liver-to-body weight ratio (C) of mice injected with AAV8-TBG-mLIF at the indicated titers. (D) Serum mLIF levels in mice injected with AAV8-TBG-mLIF at the indicated titers. (E&F) CD31 immunofluorescence staining of liver sections from mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse) (E) and quantified in (F). Scale bar=50 μm. (G) Serum HGF levels in mice injected with AAV8-TBG-mLIF at the indicated titers. (H) Liver-to-body weight ratio at the indicated time points post-PHx in mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse). (I&J) Serum mLIF (H) and HGF (I) levels at 24, 48 and 72 h post-PHx in mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse).

Journal: bioRxiv

Article Title: The LIF-LIFR Axis Promotes Liver Regeneration via Modulation of Angiogenesis and HGF Release from LSECs

doi: 10.64898/2026.02.24.707802

Figure Lengend Snippet: (A-C) Body weight (A), liver weight (B) and liver-to-body weight ratio (C) of mice injected with AAV8-TBG-mLIF at the indicated titers. (D) Serum mLIF levels in mice injected with AAV8-TBG-mLIF at the indicated titers. (E&F) CD31 immunofluorescence staining of liver sections from mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse) (E) and quantified in (F). Scale bar=50 μm. (G) Serum HGF levels in mice injected with AAV8-TBG-mLIF at the indicated titers. (H) Liver-to-body weight ratio at the indicated time points post-PHx in mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse). (I&J) Serum mLIF (H) and HGF (I) levels at 24, 48 and 72 h post-PHx in mice injected with low-doses AAV8-TBG-mLIF (1×10⁸ or 2.5×10⁸ GC/mouse).

Article Snippet: The following steps were carried out according to the manufacturer’s protocols from mLIF ELISA kit (R&D system, MLF00).

Techniques: Injection, Immunofluorescence, Staining